Page 68 - Read Online
P. 68

Diab et al. J Cancer Metastasis Treat 2022;8:42  https://dx.doi.org/10.20517/2394-4722.2022.60   Page 11 of 14

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the
                    unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21.  DOI  PubMed
               2.   Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33.  DOI  PubMed
               3.       Al-Share B, Hammad N, Diab M. Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy. Cancer Metastasis
                    Rev 2021;40:355-71.  DOI  PubMed
               4.       Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med
                    2011;364:1817-25.  DOI  PubMed
               5.       Singh RR, O’Reilly EM. New treatment strategies for metastatic pancreatic ductal adenocarcinoma. Drugs 2020;80:647-69.  DOI
                    PubMed  PMC
               6.       Väyrynen SA, Zhang J, Yuan C, et al. Composition, spatial characteristics, and prognostic significance of myeloid cell infiltration in
                    pancreatic cancer. Clin Cancer Res 2021;27:1069-81.  DOI  PubMed  PMC
               7.   Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA 2021;326:851-62.  DOI
               8.       Vaish U, Jain T, Are AC, Dudeja V. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity
                    and therapeutic targeting. Int J Mol Sci 2021;22:13408.  DOI  PubMed  PMC
               9.       Gopurappilly R, Bhat V, Bhonde R. Pancreatic tissue resident mesenchymal stromal cell (MSC)-like cells as a source of in vitro islet
                    neogenesis. J Cell Biochem 2013;114:2240-7.  DOI  PubMed
               10.       Quante M, Tu SP, Tomita H, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote
                    tumor growth. Cancer Cell 2011;19:257-72.  DOI  PubMed  PMC
               11.       Mathew E, Brannon AL, Del Vecchio A, et al. Mesenchymal stem cells promote pancreatic tumor growth by inducing alternative
                    polarization of macrophages. Neoplasia 2016;18:142-51.  DOI  PubMed  PMC
               12.       Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for
                    carcinoma-associated fibroblasts. Cancer Res 2007;67:10123-8.  DOI  PubMed
               13.       Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis.
                    J Clin Invest 2002;110:341-50.  DOI  PubMed  PMC
               14.       Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces
                    immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014;25:719-34.  DOI  PubMed  PMC
                                                               +
               15.       Chen Y, Kim J, Yang S, et al. Type I collagen deletion in αSMA  myofibroblasts augments immune suppression and accelerates
                    progression of pancreatic cancer. Cancer Cell 2021;39:548-565.e6.  DOI  PubMed  PMC
               16.       Bhattacharjee S, Hamberger F, Ravichandra A, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-
                    associated fibroblasts. J Clin Invest 2021;131:146987.  DOI  PubMed  PMC
               17.       Lee JJ, Perera RM, Wang H, et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad
                    Sci USA 2014;111:E3091-100.  DOI  PubMed  PMC
               18.       Walter K, Omura N, Hong SM, et al. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic
                    cancer-associated fibroblasts. Clin Cancer Res 2010;16:1781-9.  DOI  PubMed  PMC
               19.       Catenacci DV, Junttila MR, Karrison T, et al. Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog
                    pathway inhibitor, in patients with metastatic pancreatic cancer. J Clin Oncol 2015;33:4284-92.  DOI  PubMed  PMC
               20.       Elyada E, Bolisetty M, Laise P, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-
                    presenting cancer-associated fibroblasts. Cancer Discov 2019;9:1102-23.  DOI  PubMed  PMC
               21.       Baron M, Veres A, Wolock SL, et al. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell
                    population structure. Cell Syst 2016;3:346-360.e4.  DOI  PubMed  PMC
               22.       Bernard V, Semaan A, Huang J, et al. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and
                    microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res 2019;25:2194-205.  DOI  PubMed
                    PMC
                                                                                               +
               23.       Dominguez CX, Müller S, Keerthivasan S, et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15 myofibroblasts
                    as a determinant of patient response to cancer immunotherapy. Cancer Discov 2020;10:232-53.  DOI  PubMed
               24.       Hosein AN, Huang H, Wang Z, et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-
                    cell resolution. JCI Insight 2019;5:129212.  DOI  PubMed  PMC
               25.       Öhlund D, Handly-Santana A, Biffi G, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
                    J Exp Med 2017;214:579-96.  DOI  PubMed  PMC
               26.  Biffi G, Oni TE, Spielman B, et al. IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in
   63   64   65   66   67   68   69   70   71   72   73